BioticsAI CEO Robhy Bustami joined Isabelle Johannessen on Build Mode to discuss how the company has navigated a highly ...

The FDA rejected the promising skin cancer drug RP1 twice, leaving many puzzled and worried about what this means for other ...

Texas is helping shape the future of psychedelic therapies. Here's how they work and what access could look like.

Texas is helping shape the future of psychedelic therapies. Here’s how they work and what access could look like.

Some psychedelic drugs, once considered fringe, are now getting a step closer to possibly being approved for use as mental ...

The US Food and Drug Administration (FDA) has issued warning letters to several firms that have violated current good ...

The FDA is testing real-time clinical trial reporting in an effort to speed up the drug review and approval process.

A new FDA regulatory pathway could accelerate approval of psychedelic therapies for resistant depression and PTSD, and ...

The move comes less than a week later after President Donald Trump signed an executive order to extend research to study ...

FDA commissioner Marty Makary told NBC News that the first psychedelic drug could be approved in the U.S. as soon as this ...

The first-of-its-kind pilot could lead to speedier regulatory approval of medical drugs and devices and potentially reduce ...